Anhui, China

Beilei Wang


 

Average Co-Inventor Count = 12.2

ph-index = 1

Forward Citations = 13(Granted Patents)


Location History:

  • Hefei, CN (2017)
  • Anhui, CN (2019 - 2023)

Company Filing History:


Years Active: 2017-2025

Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents

Title: Beilei Wang: Innovator in Kinase Inhibitor Research

Introduction

Beilei Wang is a prominent inventor based in Anhui, China, known for his significant contributions to the field of kinase inhibitors. With a total of 12 patents to his name, Wang has made remarkable strides in developing pharmaceutical compositions that target specific kinase activities.

Latest Patents

Wang's latest patents include a "Pan-KIT kinase inhibitor having quinoline structure and application thereof." This invention discloses a kinase inhibitor and a pharmaceutical composition that includes the inhibitor. The compound can inhibit both wild-type and mutant KIT tyrosine kinase activity, providing potential treatments for diseases associated with these kinases. Another notable patent is the "MST1 kinase inhibitor and use thereof," which also comprises a compound that can inhibit MST1 and its mutants. This invention outlines methods for preventing or treating diseases related to MST1 kinase activity.

Career Highlights

Throughout his career, Beilei Wang has worked with esteemed organizations such as the Chinese Academy of Sciences and Therapeutics Science Inc. His work has focused on advancing the understanding and application of kinase inhibitors in medical treatments.

Collaborations

Wang has collaborated with notable colleagues, including Qingsong Liu and Jing Liu, who have contributed to his research endeavors.

Conclusion

Beilei Wang's innovative work in kinase inhibitors has the potential to significantly impact the treatment of various diseases. His contributions to the field are marked by a strong portfolio of patents and collaborations with other experts.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…